Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Surmodics Inc (SRDX)

Surmodics Inc (SRDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 504,387
  • Shares Outstanding, K 13,588
  • Annual Sales, $ 100,080 K
  • Annual Income, $ 7,590 K
  • 60-Month Beta 1.04
  • Price/Sales 5.08
  • Price/Cash Flow 28.80
  • Price/Book 4.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year 0.07
  • Growth Rate Est. (year over year) -171.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.08 +0.09%
on 02/21/20
48.68 -23.75%
on 02/06/20
-3.98 (-9.68%)
since 01/21/20
3-Month
37.08 +0.09%
on 02/21/20
48.68 -23.75%
on 02/06/20
-2.74 (-6.87%)
since 11/21/19
52-Week
37.08 +0.09%
on 02/21/20
58.84 -36.91%
on 03/01/19
-19.29 (-34.20%)
since 02/21/19

Most Recent Stories

More News
Surmodics (SRDX) Q1 Earnings Beat Estimates, Revenues Miss

Surmodics' (SRDX) fiscal first-quarter earnings benefit from higher revenues, segmental growth and strong fiscal 2020 outlook.

ARAY : 3.32 (-1.48%)
SYK : 224.30 (-0.08%)
SRDX : 37.12 (-0.88%)
ABC : 97.00 (+0.49%)
Surmodics to Host Virtual Annual Meeting of Shareholders

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, will hold its Annual Meeting of Shareholders on Thursday, February...

SRDX : 37.12 (-0.88%)
SurModics (SRDX) Surpasses Q1 Earnings Estimates

SurModics (SRDX) delivered earnings and revenue surprises of 266.67% and -0.89%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

SRDX : 37.12 (-0.88%)
Surmodics Reports First Quarter Fiscal 2020 Results

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2020 first quarter ended December...

SRDX : 37.12 (-0.88%)
Surmodics Names Nusrath Sultana, MD, as Vice President, Clinical Affairs

Surmodics, Inc. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced today Nusrath Sultana, MD, has joined Surmodics as Vice President,...

SRDX : 37.12 (-0.88%)
Earnings Preview: SurModics (SRDX) Q1 Earnings Expected to Decline

SurModics (SRDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SRDX : 37.12 (-0.88%)
Surmodics to Webcast First Quarter Fiscal 2020 Earnings Conference Call on February 5

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its first quarter...

SRDX : 37.12 (-0.88%)
Here's Why You Should Retain Surmodics (SRDX) Stock for Now

Surmodics (SRDX) is gaining from continued strength at Medical Devices unit and persistent efforts to boost R&D functionalities. However, weak performance at Surmodics' IVD unit remains a concern.

SRDX : 37.12 (-0.88%)
XRAY : 56.85 (-1.03%)
WST : 170.16 (-0.88%)
CAH : 59.72 (-1.16%)
Shares of SRDX Down -2.4% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Surmodics Inc (NASDAQ:SRDX) on November 1st, 2019 at $41.07. In approximately 1 month, Surmodics Inc has returned 2.42% as of today's recent price of $42.06.

SRDX : 37.12 (-0.88%)
Here's Why You Should Hold on to Surmodics (SRDX) Stock Now

Surmodics (SRDX) is gaining from continued strength at Medical Devices unit and persistent efforts to boost R&D functionalities. However, weak performance at Surmodics' IVD unit remains a concern.

SRDX : 37.12 (-0.88%)
XRAY : 56.85 (-1.03%)
CNMD : 103.55 (-0.31%)
CAH : 59.72 (-1.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade SRDX with:

Business Summary

SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring...

See More

Key Turning Points

2nd Resistance Point 37.89
1st Resistance Point 37.51
Last Price 37.12
1st Support Level 36.91
2nd Support Level 36.70

See More

52-Week High 58.84
Fibonacci 61.8% 50.53
Fibonacci 50% 47.96
Fibonacci 38.2% 45.40
Last Price 37.12
52-Week Low 37.08

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar